NIVA BUPA HEALTH INSURANCE COMPANY LIMITED
₹72.62-₹0.84 (-1.1%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹14,417 Cr
- P/E
- 156.0x
- EV / EBITDA
- 130.9x
- Revenue
- ₹5,374 Cr
- Net margin
- 2.0%
- ROCE
- 0.8%
Price chart
Technical chartScreen technicals →-3.0% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -3.1%
- 3M
- -15.5%
- 6M
- -7.1%
- 1Y
- -3.0%
- 5Y
- -1.9%
52-week range
Day change -₹0.84 (-1.1%) from ₹73 to ₹73 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in NIVABUPA, bought on each weekday since 2024.
AI Summary
Indian StockStrengths1
- Strong 5-year revenue CAGR of 31.2%
Concerns1
- Low return on equity of 7.0%
Rule-based from financial data. Not advice.
About the company
Niva Bupa Health Insurance Company Limited provides health insurance products in India.
Read moreShow less
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.
- Sector
- Financial Services
- Shares outstanding
- 185 Cr shares
- ISIN
- INE995S01015
- BSE code
- 544286
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹14,417 Cr
- P/E
- 156.0x
- P/B
- 3.8x
- EV / EBITDA
- 130.9x
- EV / Sales
- 3.5x
- P/S
- 3.5x
- Earnings yield
- 0.6%
- 52-week high
- ₹88.36
- 52-week low
- ₹68.60
Profitability
- Operating margin
- -2.7%
- Net margin
- 2.0%
- EBITDA margin
- 2.7%
- ROE
- 7.0%
- ROCE
- 0.8%
- ROA
- 1.3%
- Dividend payout
- 0.0%
- Tax rate
- 0.0%
- Other income, % of PBT
- 273.2%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹5,374 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 30.6%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 31.2%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹111 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 152.3%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 161.0%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹813 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 37.1%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹78.0 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 59.7%
Solvency and efficiency
- Current ratio
- 1.58
- Debt / Assets
- 0.04
- Debt / EBITDA
- 2.25
- Financial leverage
- 3.02
- CFO / Net profit
- 9.91
- Cash / Market cap
- 4.7%
- Cash per share
- ₹3.65
- Asset turnover
- 0.66
- Fixed asset turnover
- 70.95
- Capital intensity
- 0.01
- Debtor days
- 0 days
- Cash conversion cycle
- 0 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹4 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹5,296 Cr |
| Sales | Operating profit | ₹78 Cr |
| Operating profit | Depreciation | ₹25 Cr |
| Operating profit | Profit before tax | ₹53 Cr |
| Other income | Profit before tax | ₹160 Cr |
| Profit before tax | Net profit | ₹214 Cr |
Revenue and net profit
Revenue grew 30.6% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹1,413 Cr | -₹50 Cr |
| FY2022 | ₹1,877 Cr | -₹197 Cr |
| FY2023 | ₹2,853 Cr | ₹13 Cr |
| FY2024 | ₹4,115 Cr | ₹82 Cr |
| FY2025 | ₹5,374 Cr | ₹214 Cr |
Cash flows
FY2025: ₹1,654 Cr from operations, -₹694 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹257 Cr | -₹117 Cr |
| FY2022 | ₹338 Cr | -₹385 Cr |
| FY2023 | ₹593 Cr | -₹236 Cr |
| FY2024 | ₹813 Cr | -₹1,069 Cr |
| FY2025 | ₹1,654 Cr | -₹694 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹5,374 Cr+30.6%1Y
- Net profit
- ₹214 Cr+161.0%1Y
- Cash from operations
- ₹1,654 Cr
- Free cash flow
- -₹694 Cr
- Revenue CAGR, 5Y
- 31.2%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹5,374 Cr | ₹78 Cr | — | ₹214 Cr | ₹1,654 Cr | -₹694 Cr | 7.0% | +30.6% | +161.0% |
Monthly returns
Month-by-month returns of NIVABUPA across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹9,760 Cr |
| Equity capital | ₹1,827 Cr |
| Reserves | ₹1,231 Cr |
| Borrowings | ₹250 Cr |
| Other liabilities | ₹6,452 Cr |
| Assets | ₹9,760 Cr |
| Fixed assets | ₹66 Cr |
| Capital work in progress | ₹9 Cr |
| Investments | ₹8,175 Cr |
| Other assets | ₹1,510 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
NIVABUPA trades at 156.0x earnings against a peer median of 26.9x (a 480% premium).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| NIVA BUPA HEALTH INSURANCE COMPANY LIMITEDNIVABUPAthis companyP/E ↑ premium | ₹14,417 Cr | 156.0x | 3.8x | 7.0% | 130.9x |
| Maharashtra Scooters Ltd.MAHSCOOTER | ₹15,766 Cr | 50.8x | 0.5x | 0.7% | 77.3x |
| IFCI Ltd.IFCI | ₹15,574 Cr | 65.7x | 8.8x | 2.5% | 18.3x |
| Five-Star Business Finance Ltd.FIVESTAR | ₹15,268 Cr | 13.8x | 2.2x | 17.0% | — |
| UTI Asset Management Company LimitedUTIAMC | ₹13,871 Cr | 21.4x | 3.9x | 17.3% | 17.0x |
| Aptus Value Housing Finance India LimitedAPTUS | ₹13,728 Cr | 20.6x | 3.4x | 15.2% | 17.2x |
| Canara HSBC Life Insurance Company LimitedCANHLIFE | ₹13,445 Cr | 111.0x | — | 7.7% | 89.7x |
| JM Financial LimitedJMFINANCIL | ₹12,963 Cr | 22.3x | 2.8x | 12.1% | 30.1x |
| Indian Energy Exchange LimitedIEX | ₹12,598 Cr | 28.0x | 10.4x | 37.8% | 26.1x |
| Peer median | — | 26.9x | 2.8x | 12.3% | 33.9x |
Year-to-date ROI
NIVABUPA since 1 January, against earlier years.
Historical volatility
NIVABUPA's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | -2.0% |
| FY2022 | -24.0% |
| FY2023 | -12.0% |
| FY2024 | -3.0% |
| FY2025 | 1.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹5,374 Cr |
| Costs | |
| Interest | ₹0 Cr |
| Expenses | ₹5,296 Cr |
| Operating profitOperating Profit | ₹78 Cr |
| Other income and charges | |
| Profit before tax | ₹214 Cr |
| Tax | |
| Net profitNet Profit | ₹214 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹9,760 Cr |
| Equity capitalEquity Capital | ₹1,827 Cr |
| Reserves | ₹1,231 Cr |
| Borrowings | ₹250 Cr |
| Other liabilitiesOther Liabilities | ₹6,452 Cr |
| AssetsTotal Assets | ₹9,760 Cr |
| Fixed assetsFixed Assets | ₹66 Cr |
| Capital work in progressCWIP | ₹9 Cr |
| Investments | ₹8,175 Cr |
| Other assetsOther Assets | ₹1,510 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹1,654 Cr |
| Investing cash flowCash from Investing Activity | -₹2,348 Cr |
| Financing cash flowCash from Financing Activity | ₹771 Cr |
| Change in cashNet Cash Flow | ₹78 Cr |
Learn while you research
Academy chapters picked for NIVA BUPA HEALTH INSURANCE COMPANY LIMITED and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 156.0, learn when high multiples are justified.6 min read
- 04 Growth Investing31% revenue growth is in the top tier, learn how to value growth.7 min read
- 05 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 06 Sector AnalysisBanks & financials are uniquely sensitive to rates and credit cycles.6 min read